Delivery Order SPE2DR25D2011-SPE2DR26FADMA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,353.73 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count) with a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, serving the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.57 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units). This contract type is a firm fixed-price delivery order with no set-aside designation, executed on June 17, 2025, with an ultimate completion date of June 18, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 14, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count) valued at $9,632.65. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,250.30 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) under a firm fixed-price contract. The award, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $17,820.21 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units) with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mesalamine is a pharmaceutical treatment primarily used for inflammatory bowel...
- The Defense Logistics Agency awarded a $3,525.60 delivery order to AmerisourceBergen Drug Corp for Mesalamine ER 0.375 gram capsules (120-count) on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $7,361.02 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mesalamine 400 mg capsules (180-count units). This non-set-aside contract features firm fixed pricing and is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $2,652.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $4,066.22 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,803.07 on September 15, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count). This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADMADelivery Order
The Defense Logistics Agency awarded a $4,928.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units), with performance in Conshohocken, Pennsylvania and a completion deadline of December 2, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.999 billion ceiling value through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts predominantly with the Defense Logistics Agency. The company's federal awards consistently demonstrate capability in delivering diverse pharmaceutical products including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Mesalamine, a gastrointestinal therapeutic agent, exemplifies the company's role as a critical vendor in the federal medical supply chain serving military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 11/30/25 |